Boulder, CO – Watchmaker Genomics, an innovator in high-performance tools for molecular diagnostic (MDx) assay developers, today announced the expansion of its MDx tools portfolio with the launch of Stellar RT-qPCR and qPCR Kits. Together with Watchmaker’s Recombinase Polymerase Amplification (RPA) enzyme suite, the portfolio now enables assay developers to design across both PCR and isothermal modalities to […]
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments OXFORD, UK — ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools […]
Agreement adds STR, SNP, microhaplotype and mitochondrial DNA MPS kits to Promega forensic product lineup Madison, WI USA. — Forensic casework laboratories will now have access to NimaGen’s IDseek® massively parallel sequencing (MPS) kit portfolio through Promega Corporation, following a distribution agreement announced today between the two companies. The IDseek® line is powered by NimaGen’s patented Reverse […]
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. SAN DIEGO — Illumina (NASDAQ: ILMN) and the Center for Data-Driven Discovery in Biomedicine (D3b) today announced a data partnership to advance research in pediatric cancer and rare disease. Through cloud-based data platforms, the global research community can unify and analyze […]
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications Bio-Rad anti-idiotypic antibodies HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction of eight antibodies specific to romosuzumab […]
SPT Labtech and EMBL GeneCore Collaborate to Advance Fully Walkaway Automation in Genomics Workflows
firefly+ liquid handling platform installed at EMBL GeneCore Collaboration to enable more streamlined end-to-end workflows while maintaining sample integrity Cambridge, UK, and Heidelberg, Germany: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory’s Genomics Core Facility (EMBL GeneCore), today announced a collaboration […]
North Brunswick, NJ – Distek, Inc., a leading provider of pharmaceutical and bioprocessing instrumentation, announced an exclusive manufacturers’ representative agreement with Optimal Biotech Group, LLC to support its BIOne benchtop bioreactor solutions across California, Oregon, and Washington. Through this agreement, Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor […]
CAMBRIDGE, England — Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform designed for scientists who need faster and higher quality decisions without compromising data integrity. Delivering results in 55 minutes – up to 6× faster than traditional colorimetric ELISAs, SimpleStep Ignite™ combines 50× greater sensitivity with an up to 35× […]
SHENZHEN, China — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that have helped transform genomics into a scalable, data-driven and accessible engine of discovery. Since its founding in 2016, MGI has tackled the fundamental […]
SALT LAKE CITY — NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling. NomosLogic operates as an infrastructure layer for molecular medicine rather than a point product. Its integrated stack includes: TRINITY, a deterministic multi-omic fusion engine […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
